» Articles » PMID: 11426972

Production of Steroids by Human Ovarian Surface Epithelial Cells in Culture: Possible Role of Progesterone As Growth Inhibitor

Overview
Journal Gynecol Oncol
Date 2001 Jun 28
PMID 11426972
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose was to investigate whether normal ovarian surface epithelial cells, harvested from premenopausal and postmenopausal women, are capable of steroid production, and to evaluate effects of estradiol and progesterone on growth regulation of such cells.

Methods: Ovarian surface epithelial cells were obtained by brushing of the ovarian surface of 9 premenopausal and 10 postmenopausal women undergoing surgery for benign gynecological diseases. The conditioned media after culture, with and without addition of FSH and LH, were analyzed for estradiol and progesterone. The proliferative effects of the steroids were analyzed using two different culture models, nonconfluent cells and confluent cells, and two different detection methods, [(3)H]thymidine incorporation and a colorimetric method assaying cell number.

Results: The normal ovarian surface epithelial cells were found to secrete both estradiol and progesterone, a production that was not regulated by FSH or LH. Addition of steroids to the cultured cells did not induce any overall significant growth effects. However, progesterone significantly inhibited the growth of ovarian surface epithelial cells from three of the patients. Enhanced thymidine incorporation was observed in the presence of the progesterone receptor antagonist Org 31710 in the nonconfluent cultures of cells from postmenopausal women, but no effect of an estrogen receptor antagonist was observed.

Conclusions: The normal ovarian surface epithelium is capable of steroid production, which is also often observed in tissue from ovarian epithelial tumors. Progesterone appeared to be a negative regulator of ovarian surface epithelial growth, while estradiol had no effect.

Citing Articles

The Chemoprevention of Ovarian Cancer: the Need and the Options.

Kathawala R, Kudelka A, Rigas B Curr Pharmacol Rep. 2018; 4(3):250-260.

PMID: 30363743 PMC: 6182352. DOI: 10.1007/s40495-018-0133-6.


Clinicopathological significance of steroidogenic factor-1 expression in ovarian cancer versus ovarian sex cord stromal tumor.

Hu Z, Tang L, Zhang H, Niu J, Lou M Tumour Biol. 2015; 36(3):1429-35.

PMID: 25604140 DOI: 10.1007/s13277-014-2187-3.


Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Liu T, Chen L, Sun X, Wang Y, Li S, Yin X Tumour Biol. 2013; 35(3):2427-36.

PMID: 24197980 DOI: 10.1007/s13277-013-1322-x.


In vitro regulation of sheep ovarian surface epithelium (OSE) proliferation by local ovarian factors.

Saddick S Saudi J Biol Sci. 2013; 19(3):285-90.

PMID: 23961188 PMC: 3730561. DOI: 10.1016/j.sjbs.2012.03.003.


Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.

Diep C, Charles N, Gilks C, Kalloger S, Argenta P, Lange C Cell Cycle. 2013; 12(9):1433-49.

PMID: 23574718 PMC: 3674071. DOI: 10.4161/cc.24550.